Depression Treatments May Be Missing the Real Biological Cause

The Most Popular Theory of Depression Is Probably Backward

Your brain is not broken. That is the first thing you need to understand about the current state of depression research. For decades, the dominant story has been simple: depression is a chemical imbalance. Low serotonin. Not enough happy juice. The solution? A pill that boosts serotonin levels, and you will feel better.

That story is almost certainly incomplete. And a sweeping 2024 review by Lulu Cui, Shu Li, Siman Wang, and Xiafang Wu, published in Signal Transduction and Targeted Therapy, suggests something far more interesting: depression may not start in the brain at all. It may start in the rest of your body.

The paper, which synthesizes hundreds of studies and cites 850 other papers, does not just poke holes in the serotonin hypothesis. It builds a new framework. One where your gut, your immune system, your hormones, and even your mitochondria all talk to your brain. And when that conversation goes wrong, depression emerges as a symptom of a whole body problem, not a chemical glitch in a single region.

This is not a gentle tweak to existing theory. It is a potential rewrite of the entire operating manual.

The Five Hypotheses That Keep Failing

Cui and her colleagues lay out the five major theories that have dominated depression research for the last 60 years. Each one has evidence supporting it. Each one also has glaring holes.

The Neurotransmitter Hypothesis: Serotonin's Long Shadow

This is the one you know. Low levels of serotonin, norepinephrine, or dopamine cause depressive symptoms. The evidence: drugs that boost these neurotransmitters often work. The problem: they work for only about 60 percent of patients, and even then, the effect is modest. Placebo response rates in antidepressant trials are often 30 to 40 percent. If depression were simply low serotonin, Prozac should work for nearly everyone. It does not.

Cui et al. note that the neurotransmitter hypothesis cannot explain why antidepressants take weeks to work, even though they raise serotonin levels within hours. If the mechanism were purely chemical, relief should be immediate. It is not. Something else is happening during those weeks of delay.

The HPA Axis Hypothesis: Your Stress Thermostat Is Broken

The hypothalamic pituitary adrenal axis is your body's stress response system. When you are under threat, it releases cortisol. When the threat passes, it shuts off. In many depressed patients, this system stays stuck in the "on" position. Cortisol levels remain high, damaging neurons in the hippocampus, the brain region responsible for memory and mood regulation.

This hypothesis has strong biological support. Cui et al. cite studies showing that depressed patients have elevated cortisol levels and enlarged adrenal glands. But here is the catch: not all depressed patients have HPA axis dysfunction. And some people with HPA axis dysfunction never develop depression. The correlation is real, but the causality is messy.

The Cytokine Hypothesis: Inflammation as the Hidden Driver

This is where things get interesting. Cytokines are immune signaling molecules. When you get an infection, your body releases them to fight the pathogen. They also make you feel tired, sluggish, and withdrawn. Sound familiar?

Cui and her team review evidence that depressed patients have elevated levels of pro inflammatory cytokines like interleukin 6 and tumor necrosis factor alpha. These molecules can cross the blood brain barrier and directly affect neurotransmitter metabolism. They can reduce serotonin availability by activating an enzyme called indoleamine 2,3 dioxygenase, which shunts tryptophan away from serotonin production and toward neurotoxic byproducts.

This hypothesis explains something the serotonin hypothesis cannot: why chronic inflammatory diseases like rheumatoid arthritis and inflammatory bowel disease have high rates of comorbid depression. The inflammation is not a side effect of depression. It may be the cause.

The Neuroplasticity Hypothesis: Your Brain Lost Its Ability to Change

This one is more recent. The idea is that depression is not about chemical levels but about structural problems. Specifically, depressed patients show reduced neuroplasticity, the brain's ability to form new connections and adapt. The hippocampus shrinks. The prefrontal cortex thins. The connections between brain regions weaken.

Cui et al. point out that antidepressants, electroconvulsive therapy, and even exercise all increase neuroplasticity. This may be why they work. But again, the direction of causality is unclear. Does depression cause reduced neuroplasticity, or does reduced neuroplasticity make you vulnerable to depression?

The Systemic Influence Hypothesis: The Body Talks, the Brain Listens

This is the newest and most ambitious hypothesis. It argues that depression is not a brain disease at all. It is a systemic disorder that manifests in the brain.

Cui and her colleagues synthesize research showing that the gut microbiome, the liver, the adrenal glands, and even adipose tissue all communicate with the brain through hormones, immune signals, and metabolic byproducts. When these systems are disrupted by chronic stress, poor diet, sleep deprivation, or infection, they send distress signals to the brain. The brain responds by producing depressive symptoms.

This hypothesis does not replace the others. It subsumes them. The neurotransmitter changes, the HPA axis dysfunction, the inflammation, the reduced neuroplasticity, they are all downstream effects of a body that has lost its ability to maintain homeostasis.

The Gut Brain Connection: Your Second Brain Is Depressed

One of the most striking sections of the Cui et al. review focuses on the gut microbiome. The authors describe how gut bacteria produce neurotransmitters, including serotonin, dopamine, and GABA. In fact, about 90 percent of the body's serotonin is produced in the gut, not the brain.

The gut microbiome also regulates inflammation. When the balance of gut bacteria shifts, the intestinal lining becomes more permeable. Bacteria and their byproducts leak into the bloodstream, triggering systemic inflammation. That inflammation reaches the brain and alters mood.

Cui et al. cite studies showing that transplanting fecal matter from depressed humans into rats induces depressive behaviors in the rats. The reverse is also true: transplanting healthy gut bacteria can reduce depressive symptoms. This is not correlation. This is causation, at least in animal models.

The implication is uncomfortable for anyone who thinks depression is purely psychological. Your mood may be influenced by the bacteria living in your colon.

Mitochondria: The Power Plants Nobody Talks About

Another surprising player in the Cui et al. review is the mitochondrion. These cellular organelles produce energy. But they also regulate cell death, calcium signaling, and stress responses.

Depressed patients show mitochondrial dysfunction. Their cells produce less energy, generate more reactive oxygen species, and are more prone to triggering apoptosis, programmed cell death. This is especially problematic in the brain, which consumes 20 percent of the body's energy despite being only 2 percent of its mass.

Cui and her team review evidence that chronic stress damages mitochondria. Damaged mitochondria then fail to meet the brain's energy demands, leading to cognitive slowing, fatigue, and anhedonia, the inability to feel pleasure. Antidepressants may work in part by improving mitochondrial function.

This is a radical idea. Depression may be, at least in part, an energy crisis at the cellular level.

What the New Research Actually Found

The Cui et al. review is not a single experiment. It is a comprehensive synthesis of hundreds of studies. But the authors draw several clear conclusions.

First, no single hypothesis explains depression. The neurotransmitter hypothesis is not wrong, but it is incomplete. It describes a downstream effect, not a root cause.

Second, multiple organ systems are involved. The gut, the immune system, the endocrine system, and the mitochondria all interact with the brain. Depression is a disorder of this network, not a defect in one node.

Third, the best treatments may be those that target multiple systems simultaneously. The authors highlight emerging therapies like phototherapy, which affects circadian rhythms and neurotransmitter systems, and acupuncture, which may modulate inflammation and the gut brain axis.

Fourth, the authors call for a shift in diagnosis. Currently, depression is diagnosed based on symptoms. Cui et al. argue for a biomarker based approach, measuring inflammation, cortisol levels, and gut microbiome composition to identify subtypes of depression that respond to different treatments.

What This Research Does Not Prove

Let me be clear about what this paper does not claim. It does not say that antidepressants are useless. It does not say that depression is not real. It does not say that talk therapy is irrelevant.

What it says is that the current model is too simple. The serotonin hypothesis has been the dominant narrative for 40 years, but it has not led to dramatic improvements in treatment outcomes. The rate of treatment resistant depression, defined as failure to respond to two or more antidepressants, remains around 30 percent.

The Cui et al. review also does not prove that the systemic hypothesis is correct. It is a synthesis of existing evidence, not a definitive experiment. The authors themselves note that many of the studies they cite are correlational. Causal mechanisms are still being worked out.

But the weight of evidence is shifting. And the direction of that shift is clear: depression is a whole body disorder, and treating it requires a whole body approach.

Why This Matters Right Now

The practical implications of this research are immediate. If depression is driven by inflammation, then anti inflammatory drugs like NSAIDs might augment antidepressants. Early trials suggest they do. If depression is driven by gut dysbiosis, then probiotics or dietary changes might help. Some studies show they do. If depression is driven by mitochondrial dysfunction, then exercise and certain supplements like CoQ10 might improve energy metabolism. The evidence is promising.

Cui and her colleagues are not advocating for abandoning antidepressants. They are advocating for a more sophisticated approach. One that treats the body as a system, not a collection of disconnected parts.

What This Actually Means

• ▸If you have depression, get your inflammation levels checked. A simple blood test for C reactive protein can tell you if your immune system is chronically activated. If it is, anti inflammatory strategies, including diet, exercise, and possibly medications, may be more effective than antidepressants alone.
• ▸Your gut health matters. Fermented foods, high fiber diets, and probiotic supplements may improve mood by supporting a healthy microbiome. The evidence is not definitive, but it is strong enough to act on.
• ▸Exercise is not optional. It is a direct treatment for mitochondrial dysfunction, inflammation, and reduced neuroplasticity. The antidepressant effect of exercise is comparable to medication for mild to moderate depression.
• ▸One size does not fit all. The era of prescribing the same SSRI to everyone needs to end. Biomarker based diagnosis, measuring cortisol, cytokines, and gut bacteria, could match patients to treatments that actually work for their specific biology.
• ▸Depression is not a character flaw or a chemical imbalance. It is a systems failure. And systems failures require systems solutions. That means combining medication, lifestyle changes, and therapies that address the whole body, not just the brain.